Reversal of Chemotherapy Resistance to Cisplatin in NSCLC by miRNA-195-5p via Targeting the FGF2 Gene
Hao Wang,1,2 Zhi-lin Sui,1 Xian-xian Wu,1 Peng Tang,1 Hong-dian Zhang,1 Zhen-tao Yu1,3 1Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy of Tianjin City, Tianjin, 300060, People’s Republic of China; 2...
Saved in:
Main Authors: | Wang H (Author), Sui Z (Author), Wu X (Author), Tang P (Author), Zhang H (Author), Yu Z (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
by: Margherita Iaboni, et al.
Published: (2016) -
Regulation of miRNA content. Part 1. Editing miRNA. Тailing miRNA
by: A.E. Abaturov, et al.
Published: (2021) -
MiRNA biogenesis. Part 1. Maturation of pre-miRNA. Maturation of canonical miRNAs
by: A.E. Abaturov, et al.
Published: (2021) -
miRNA signature associated with outcome of gastric cancer patients following chemotherapy
by: Kim Chang, et al.
Published: (2011) -
Regulation of miRNA content. Part 2. Degradation of miRNAs
by: A.E. Abaturov, et al.
Published: (2021)